| scholarly article | Q13442814 |
| P50 | author | Eugene Braunwald | Q322114 |
| Rebecca Scherzer | Q92747306 | ||
| Andreas Kalogeropoulos | Q37842328 | ||
| Kevin J Anstrom | Q62611770 | ||
| Javed Butler | Q63107356 | ||
| P2093 | author name string | Adrian F Hernandez | |
| Eric J Velazquez | |||
| Svati H Shah | |||
| Sanjiv J Shah | |||
| Raymond J Kim | |||
| Patrice Desvigne-Nickens | |||
| Priscilla Y Hsue | |||
| P2860 | cites work | HMDB 3.0--The Human Metabolome Database in 2013 | Q24595162 |
| Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection | Q26748743 | ||
| The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds | Q26765200 | ||
| A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation | Q26850196 | ||
| Left atrium in heart failure with preserved ejection fraction: structure, function, and significance | Q26863491 | ||
| Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway | Q77476984 | ||
| Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors | Q78613843 | ||
| Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample | Q78968528 | ||
| Natriuretic peptides | Q80396416 | ||
| Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression | Q80872128 | ||
| FiehnLib: Mass Spectral and Retention Index Libraries for Metabolomics Based on Quadrupole and Time-of-Flight Gas Chromatography/Mass Spectrometry | Q27807494 | ||
| Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review | Q28755180 | ||
| Controlling the false discovery rate in behavior genetics research | Q29614833 | ||
| Multi-Ethnic Study of Atherosclerosis: objectives and design | Q29615490 | ||
| Deconvolution gas chromatography/mass spectrometry of urinary organic acids--potential for pattern recognition and automated identification of metabolic disorders | Q30657997 | ||
| HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. | Q33513977 | ||
| Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. | Q33551302 | ||
| Impact of HIV infection on diastolic function and left ventricular mass | Q33721647 | ||
| Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients | Q34061952 | ||
| Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold | Q34403474 | ||
| Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review | Q34464232 | ||
| Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. | Q34555483 | ||
| Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction | Q34623775 | ||
| Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy | Q34766189 | ||
| Galectin-3: a novel mediator of heart failure development and progression | Q34995162 | ||
| Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation | Q35021902 | ||
| N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients | Q35040620 | ||
| Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort | Q35219570 | ||
| Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients | Q35465943 | ||
| Structural heart disease and ST2: cross-sectional and longitudinal associations with echocardiography | Q35564976 | ||
| Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease | Q35584993 | ||
| Progression of left ventricular diastolic dysfunction and risk of heart failure | Q35719757 | ||
| Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. | Q35772466 | ||
| Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in patients infected with human immunodeficiency virus: a 3T cardiovascular magnetic reso | Q35828384 | ||
| Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy | Q35921028 | ||
| Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone | Q35921040 | ||
| Future challenges for clinical care of an ageing population infected with HIV: a modelling study | Q35925654 | ||
| Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals | Q35930402 | ||
| A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population. | Q35967926 | ||
| Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults | Q36208623 | ||
| Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality | Q36298226 | ||
| Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation | Q36930492 | ||
| Arterial inflammation in patients with HIV. | Q37046942 | ||
| Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania | Q37095598 | ||
| Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy | Q37492492 | ||
| HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system | Q38166148 | ||
| Immune activation during acute HIV infection and the impact of early antiretroviral therapy | Q38645268 | ||
| Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome | Q38646405 | ||
| Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study | Q38733997 | ||
| Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population | Q38851681 | ||
| Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals | Q38851822 | ||
| T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review | Q38889848 | ||
| Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation. | Q38895386 | ||
| A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure | Q39182582 | ||
| Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV. | Q39223314 | ||
| HIV-1-Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema | Q40764484 | ||
| Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients | Q40764494 | ||
| HIV patients have impaired diastolic function that is not aggravated by anti-retroviral treatment. | Q41271570 | ||
| Clinical characteristics of HIV-infected patients with adjudicated heart failure | Q41930865 | ||
| Prospective echocardiographic assessment of cardiac structure and function in Chinese persons living with HIV. | Q42227068 | ||
| Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long-term treatment with combination antiretroviral therapy | Q42275845 | ||
| Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events | Q43155073 | ||
| High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy | Q44307756 | ||
| Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV. | Q44360506 | ||
| Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction | Q44793525 | ||
| Mortality rate in patients with diastolic dysfunction and normal systolic function | Q44849860 | ||
| Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction | Q44965235 | ||
| Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication | Q45382212 | ||
| Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy | Q45395978 | ||
| Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. | Q46002204 | ||
| Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study | Q47377837 | ||
| Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women | Q47885299 | ||
| Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. | Q48405753 | ||
| Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging | Q48686374 | ||
| Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging | Q49060993 | ||
| Arterial Stiffness Is Associated With Regional Ventricular Systolic and Diastolic Dysfunction | Q57736231 | ||
| Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients | Q61439957 | ||
| P433 | issue | 4 | |
| P921 | main subject | diastole | Q492905 |
| Diastolic function | Q30314111 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 255-265 | |
| P577 | publication date | 2018-02-23 | |
| P1433 | published in | Journal of Cardiac Failure | Q2134415 |
| P1476 | title | Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study. | |
| P478 | volume | 24 |
Search more.